Home › Funds › Commodore Capital LP › IKT

Commodore Capital LP position in IKT

INHIBIKASE THERAPEUTICS INC · Health Care

Commodore Capital LP reported holding 5,397,488 shares of IKT (INHIBIKASE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$11.0M, representing 0.65% of its reported portfolio and ranking #27 among its reported holdings. Commodore Capital LP has disclosed IKT holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)5.40M sh
Reported value held$10.96M
Portfolio Weight0.65%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's IKT position evolved

Commodore Capital LP first disclosed a stake in IKT in Q4 2024 at 5,925,000 shares (US$19.3M). Across 7 filings, Commodore Capital LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 5,397,488 shares valued at US$11.0M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 5.92M $19.26M New
Q1 2025 5.34M $11.70M Reduce
Q2 2025 5.40M $10.53M Add
Q3 2025 5.40M $8.74M Hold
Q4 2025 5.40M $11.06M Hold
Q1 2026 5.40M $9.07M Hold
Q2 2026 5.40M $10.96M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IKT and 13F data

IKT (INHIBIKASE THERAPEUTICS INC) is a Health Care company. 69 other funds we track also report a position in IKT — the largest reported positions include Sands Capital Alternatives, LLC (US$26.4M), Soleus Capital Management, L.P. (US$22.1M), Trails Edge Capital Partners, LP (US$18.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IKT

All IKT fund holders →

FAQ

How long has Commodore Capital LP held IKT?

Commodore Capital LP has disclosed IKT holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Commodore Capital LP's current position in IKT?

As of Q2 2026, Commodore Capital LP holds 5.40M shares of IKT (INHIBIKASE THERAPEUTICS INC), valued at $10.96M, representing 0.65% of its reported portfolio and ranking #27.

Has Commodore Capital LP been buying or selling IKT?

In the latest 13F filing (Q2 2026), Commodore Capital LP held unchanged its position in IKT.

Which other funds hold IKT?

Other major institutional holders of IKT include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.